FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129783818> ?p ?o ?g. }

• W2129783818 endingPage "7290.2012.00039" @default.
• W2129783818 startingPage "7290.2012.00039" @default.
• W2129783818 abstract "Imaging tumors and their response to treatment could be a valuable biomarker toward early assessment of therapy in patients with cancer. Phosphatidylserine (PS) is confined to the inner leaflet of the plasma membrane in normal cells but is externalized on tumor vascular endothelial cells (ECs) and tumor cells, and PS exposure is further enhanced in response to radiation and chemotherapy. In the present study, we evaluated the potential of a PS-targeting human F(ab')2 antibody fragment, PGN650, to detect exposure of PS in tumor-bearing mice. Tumor uptake of PGN650 was measured by near-infrared optical imaging in human tumor xenografts in immunodeficient mice. PGN650 specifically targeted tumors and was shown to target CD31-positive ECs and tumor cells. Tumor uptake of PGN650 was significantly higher in animals pretreated with docetaxel. The peak tumor to normal tissue (T/N) ratio of probe was observed at 24 hours postinjection of probe, and tumor binding was detected for at least 120 hours. In repeat dose studies, PGN650 uptake in tumors was significantly higher following pretreatment with docetaxel compared to baseline uptake prior to treatment. PGN650 may be a useful probe to detect PS exposed in tumors and to monitor enhanced PS exposure to optimize therapeutic agents to treat tumors." @default.
• W2129783818 created "2016-06-24" @default.
• W2129783818 creator A5001769338 @default.
• W2129783818 creator A5013650072 @default.
• W2129783818 creator A5059163027 @default.
• W2129783818 creator A5060192042 @default.
• W2129783818 creator A5066280939 @default.
• W2129783818 creator A5071884187 @default.
• W2129783818 creator A5089777135 @default.
• W2129783818 creator A5090080497 @default.
• W2129783818 date "2013-06-01" @default.
• W2129783818 modified "2023-09-28" @default.
• W2129783818 title "Measuring Response to Therapy by Near-Infrared Imaging of Tumors Using a Phosphatidylserine-Targeting Antibody Fragment" @default.
• W2129783818 cites W1501982791 @default.
• W2129783818 cites W1537822904 @default.
• W2129783818 cites W1597573955 @default.
• W2129783818 cites W1971847174 @default.
• W2129783818 cites W1973148734 @default.
• W2129783818 cites W1976547269 @default.
• W2129783818 cites W1977254519 @default.
• W2129783818 cites W1982322665 @default.
• W2129783818 cites W1983985735 @default.
• W2129783818 cites W1995472148 @default.
• W2129783818 cites W2009240587 @default.
• W2129783818 cites W2021085116 @default.
• W2129783818 cites W2024907000 @default.
• W2129783818 cites W2026511823 @default.
• W2129783818 cites W2026653301 @default.
• W2129783818 cites W2029070398 @default.
• W2129783818 cites W2040328643 @default.
• W2129783818 cites W2049128343 @default.
• W2129783818 cites W2062257866 @default.
• W2129783818 cites W2069869178 @default.
• W2129783818 cites W2073634074 @default.
• W2129783818 cites W2086268589 @default.
• W2129783818 cites W2087379950 @default.
• W2129783818 cites W2091281748 @default.
• W2129783818 cites W2136929548 @default.
• W2129783818 cites W2138952800 @default.
• W2129783818 cites W2144186245 @default.
• W2129783818 cites W2147531177 @default.
• W2129783818 cites W2156095955 @default.
• W2129783818 cites W2157603089 @default.
• W2129783818 cites W2161067284 @default.
• W2129783818 cites W2163777386 @default.
• W2129783818 cites W2168748433 @default.
• W2129783818 cites W2171646516 @default.
• W2129783818 doi "https://doi.org/10.2310/7290.2012.00039" @default.
• W2129783818 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3996142" @default.
• W2129783818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23651502" @default.
• W2129783818 hasPublicationYear "2013" @default.
• W2129783818 type Work @default.
• W2129783818 sameAs 2129783818 @default.
• W2129783818 citedByCount "9" @default.
• W2129783818 countsByYear W21297838182014 @default.
• W2129783818 countsByYear W21297838182016 @default.
• W2129783818 countsByYear W21297838182017 @default.
• W2129783818 countsByYear W21297838182018 @default.
• W2129783818 countsByYear W21297838182020 @default.
• W2129783818 countsByYear W21297838182022 @default.
• W2129783818 crossrefType "journal-article" @default.
• W2129783818 hasAuthorship W2129783818A5001769338 @default.
• W2129783818 hasAuthorship W2129783818A5013650072 @default.
• W2129783818 hasAuthorship W2129783818A5059163027 @default.
• W2129783818 hasAuthorship W2129783818A5060192042 @default.
• W2129783818 hasAuthorship W2129783818A5066280939 @default.
• W2129783818 hasAuthorship W2129783818A5071884187 @default.
• W2129783818 hasAuthorship W2129783818A5089777135 @default.
• W2129783818 hasAuthorship W2129783818A5090080497 @default.
• W2129783818 hasBestOaLocation W21297838181 @default.
• W2129783818 hasConcept C121608353 @default.
• W2129783818 hasConcept C126322002 @default.
• W2129783818 hasConcept C142724271 @default.
• W2129783818 hasConcept C159654299 @default.
• W2129783818 hasConcept C185592680 @default.
• W2129783818 hasConcept C203014093 @default.
• W2129783818 hasConcept C2778918659 @default.
• W2129783818 hasConcept C2778939058 @default.
• W2129783818 hasConcept C2779637612 @default.
• W2129783818 hasConcept C2780394083 @default.
• W2129783818 hasConcept C2781190966 @default.
• W2129783818 hasConcept C2781197716 @default.
• W2129783818 hasConcept C41625074 @default.
• W2129783818 hasConcept C502942594 @default.
• W2129783818 hasConcept C55493867 @default.
• W2129783818 hasConcept C71924100 @default.
• W2129783818 hasConceptScore W2129783818C121608353 @default.
• W2129783818 hasConceptScore W2129783818C126322002 @default.
• W2129783818 hasConceptScore W2129783818C142724271 @default.
• W2129783818 hasConceptScore W2129783818C159654299 @default.
• W2129783818 hasConceptScore W2129783818C185592680 @default.
• W2129783818 hasConceptScore W2129783818C203014093 @default.
• W2129783818 hasConceptScore W2129783818C2778918659 @default.
• W2129783818 hasConceptScore W2129783818C2778939058 @default.
• W2129783818 hasConceptScore W2129783818C2779637612 @default.
• W2129783818 hasConceptScore W2129783818C2780394083 @default.
• W2129783818 hasConceptScore W2129783818C2781190966 @default.
• W2129783818 hasConceptScore W2129783818C2781197716 @default.

• next